Sundial Growers: Analysts Expect Positive EBITDA For Second Quarter

Sundial Growers Inc. (Nasdaq: SNDL) announced that they will be reporting their second quarter financials after the market closes on August 12.

Analysts have a consensus $0.68 12-month price target on the company, via a total of 5 analysts, with 4 analysts having a hold rating, and one analyst has a sell rating. The street high comes from ATB Capital Markets with a $0.80 price target, and the lowest target comes in at a $0.45 price target.

Four analysts have revenue estimates for the second quarter. The mean between all 4 is C$10.12 million; this number has been revised slightly downwards from C$18.45 million at the start of the year. The street high is C$12.08 million while the lowest sits at C$8 million.

Two analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 32.50%, with this number being revised slightly higher from 28.30% at the start of the year. Street high goes to ATB Capital with a 40% estimate and the lowest sits at 25%.

Onto EBITDA estimates, there are currently only 3 analysts who have second quarter EBITDA estimates. The mean is currently C$0.63 million, with this number being higher than at the start of the year. Street high comes in at C$8 million EBITDA estimate and the lowest being a (C$5.6) million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Higher Gold Prices Are Changing What Counts as a Real Discovery | Mike Bennett – Altamira Gold

Why Silver Still Hasn’t Seen the Real Mania | Craig Hemke

Why Copper Needs a Much Higher Price to Fix the Supply Problem | Greg Ferron – PTX Metals

Recommended

First Phosphate Lifts Bégin-Lamarche Indicated Tonnage by 378% In Latest Resource Update

Higher Gold Prices Are Changing What Counts as a Real Discovery | Mike Bennett – Altamira Gold

Related News

Canaccord: 2020 To Be Transition Year For Medipharm Labs

Last week, Medipharm Labs (TSX: LABS) reported their second-quarter earnings. Revenue came in at $13.9...

Saturday, August 22, 2020, 01:38:00 PM

Sundial Reveals 10.1% Stake In The Valens Company

In an unexpected announcement this morning, it appears that Sundial Growers (NASDAQ: SNDL) is eyeing...

Tuesday, May 4, 2021, 07:12:44 AM

Cineplex: Canaccord Reiterates $7.00 Target, Upgrades To Hold

Cineplex Inc (TSX: CGX) reported their third quarter results on Friday, reporting revenues of $61...

Tuesday, November 17, 2020, 12:07:00 PM

Curaleaf: Cormark Upgrades To Buy Rating, Canaccord, Haywood Raise Price Targets

After Curaleaf’s (CSE: CURA) record-breaking second-quarter numbers, analysts have upgraded their twelve-month price targets. Curaleaf...

Wednesday, August 19, 2020, 11:29:55 AM

Well Health: PI Financial Raises Price Target To $7.00 On Back Of Circle Acquisition

This week WELL Health Technologies (TSX: WELL) announced that they are expanding into the US...

Friday, September 4, 2020, 01:38:00 PM